Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PPacira BioSciences, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Pacira BioSciences, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financials
Income statement income statement flow. Revenue $192.4M. Net result $4.65M.

Income statement revenue $192.4M (+6.2% YoY).Operating income $4.27M (-49.8% YoY).Pre-tax result $2.56M.Net result $4.65M.

  • Bupivacaine Liposome Injectable Suspension: $3.22M (+533.1% YoY)
  • EXPAREL: $147.82M (+3.4% YoY)
  • Iovera: $6.81M (+21.8% YoY)
  • Royalty: $1.91M (+153.5% YoY)
  • ZILRETTA: $32.65M (+4.2% YoY)
  • Operating costs: $143.97M
  • Other expense: $1.71M (-83.6% YoY)
  • Income tax benefit: $2.1M